SCHEMBL4647905

SCHEMBL4647905

CC(C)(C)Sc1ccc(NC(=O)C=COc2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.48
HIF1A Q16665 3/20 0.46
LMNA P02545 5/20 0.45
KMT2A Q03164 4/20 0.44
THRB P10828 2/20 0.44
EGFR P00533 4/20 0.44
KDM4E B2RXH2 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MEN1 O00255 3/20 0.44
MMP1 P03956 2/20 0.44
MMP2 P08253 2/20 0.44
MMP9 P14780 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
MAPT P10636 5/20 0.43
TGM2 P21980 1/20 0.42
TRPV1 Q8NER1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9989248 1.00 ALDH1A1 (0.48) ALDH1A1HIF1ALMNAKMT2ATHRB
SCHEMBL4649146 0.85 ALDH1A1 (0.62) ALDH1A1HIF1ALMNAKMT2ATHRB
SCHEMBL4649121 0.84 ALDH1A1 (0.51) ALDH1A1LMNAKMT2ATHRBEGFR
SCHEMBL4645874 0.82 ALDH1A1 (0.57) ALDH1A1HIF1ALMNATHRBEGFR
SCHEMBL4645411 0.82 ALDH1A1 (0.52) ALDH1A1HIF1ALMNAKMT2ATHRB
SCHEMBL4645027 0.81 MMP1 (0.61) ALDH1A1LMNAKMT2ATHRBEGFR
SCHEMBL4646880 0.80 EGFR (0.64) ALDH1A1LMNAKMT2ATHRBEGFR
SCHEMBL4646849 0.80 MMP1 (0.68) ALDH1A1LMNAKMT2ATHRBEGFR
SCHEMBL4647932 0.79 MAPT (0.54) ALDH1A1HIF1ALMNAKMT2ATHRB
SCHEMBL4647079 0.79 MAPT (0.54) ALDH1A1HIF1ALMNAKMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8410316-B2 Iminopropene compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-04-02 US disclosed
US-20110319437-A1 IMINOPROPENE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-12-29 US disclosed
EP-1957459-A2 IMINOPROPENE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-08-20 EP disclosed
WO-2007063702-A2 IMINOPROPENE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319437-A1 IMINOPROPENE COMPOUND AND USE THEREOF IMPA1, INPP5A, CTRL ALDH1A1 2213/4885HIF1A 4805/4885LMNA 417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.